Fialuridine

N/A

Report date: 2024/06/27 20:00:09
NME

Base Information

Drug NameFialuridine
Drug Alias Namefialuridinum非阿尿苷fialuridinefialuridinaFIAU
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionHBV DNA Polymerase inhibitors
TargetsHBV DNA Polymerase
Therapy Area/IndicationsHerpes SimplexHepatitis BHIV Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAllergan PlcNational Institute of Health, Islamabad
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiomed Valley Discoveries IncNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsHerpes SimplexHepatitis BHIV Infections +[4] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG